Contraindications Are a Labelling Job, Not a Footnote: What an EMS Device Manual Must Carry Before It Ships
For EMS beauty devices sold into the EU and UK, safety warnings about implanted electronics, pregnancy, cardiac conditions and neck/chest use must appear on both label and manual – a shared duty that turns missing lines into recall risks.
Regulatory affairs leads at distributors know that contraindications are not optional footnotes but core safety information. For an EMS device with multi-colour light (610–1200 nm range), IPX4 ingress and 1,200–2,000 mAh battery, the instructions for use must explicitly state avoidance by users with pacemakers, implantable defibrillators or other active implanted electronics.
Pregnancy constitutes another non-negotiable contraindication; the manual and label must clearly advise against abdominal or lumbar EMS application during gestation due to lack of fetal safety data, a point that applies equally to the device’s RF and SLIM modes.
Cardiac conditions such as arrhythmia or recent myocardial infarction require explicit warning against thoracic EMS application, especially given the device’s vibration massage and lifting functions that encourage chest-area use – the labelling must reflect this risk regardless of OEM or ODM supply arrangement.
The neck and upper chest represent a third high-risk zone where EMS current density can affect carotid sinus or vagal tone; here the angle is operational: compliance owns the wording but labelling and manual teams must execute it identically, because a mismatch creates confusion that regulators treat as a labelling failure.
When a single line on implanted devices is missing from the label but present in the manual, market surveillance authorities in the EU and UK view it as an incomplete safety message – not a footnote error but a potential recall trigger that shifts liability upstream to the distributor who failed to verify both carries the same warning.